A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer

Autor: Floudas, Charalampos S., Brar, Gagandeep, Mabry-Hrones, Donna, Duffy, Austin G., Wood, Bradford, Levy, Elliot, Krishnasamy, Venkatesh, Fioravanti, Suzanne, Bonilla, Cecilia M., Walker, Melissa, Morelli, Maria Pia, Kleiner, David E., Steinberg, Seth M., Figg, William D., Greten, Tim F., Xie, Changqing
Zdroj: In Clinical Colorectal Cancer December 2019 18(4):e349-e360
Databáze: ScienceDirect
Externí odkaz: